xtalpi

Keep you updated

with the latest info of XtalPi

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration
XtalPi Invests in MIT-Led Foundry Bio, Harnessing Generative AI to Transform the Trillion-Dollar Anti-Aging Market
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations 
Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
Unlock Faster, More Accurate Drug Discovery with XFEP
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)
Cocrystal Synthesis through Crystal Structure Prediction
Effect of Polymer Additives on the Crystal Habit of Metformin HCl
Elucidate the Crystal Structure of a Poorly Crystalline Compound in 2 Weeks with MicroED and Targeted CSP
Crystal Structure Prediction (CSP) De-risks Polymorph Instability by Providing a Deep Insight Into All Stable Forms
Enhanced Salt Screening With Rational Experimental Design Guided by Salt Formation Propensity Prediction Model

Search XtalPi

Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates

XtalPi Newsletter